Paradigm Diagnostics Competitors and Similar CompaniesClear all
Divide & Conquer's competitors and similar companies include ARIAD Pharmaceuticals and TRON.
 Divide & Conquer Divide & Conquer is focused on developing new therapeutics against glioblastoma (grade IV astrocytoma), a particularly lethal form of brain cancer, and other solid tumors with very poor life expectancy. |  ARIAD Pharmaceuticals ARIAD Pharmaceuticals is a global oncology company focused on discovering, developing and commercializing precision therapies for patients with rare cancers. |  TRON TRON Mainz is a biopharmaceutical research organization that offers diagnostics and drugs for the treatment of cancer and other severe diseases. | |
Founding Date | Founding Date 2018 | Founding Date 1991 | Founding Date 2010 |
Type | Type Private | Type Subsidiary | Type Private |
Tags | |||
Locations | Locations Babraham, GB HQ | Locations Cambridge, US HQ Boston, US Chicago, US Cincinnati, US Dallas, US Minneapolis, US New York, US see more | Locations Mainz, DE HQ |
Employees | Employees 2 | Employees 1381% increase | Employees 1903% increase |
For sources of this data, please see the company profile
View Company Profiles
ARIAD Pharmaceuticals
HQ
Cambridge, US
ARIAD Pharmaceuticals is a global oncology company focused on discovering, developing and commercializing precision therapies for patients with rare cancers.
View companyTRON
HQ
Mainz, DE
Employees
190↑ 3% increase
TRON Mainz is a biopharmaceutical research organization that offers diagnostics and drugs for the treatment of cancer and other severe diseases.
View company